# Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-128800 in Healthy Subjects

> **NCT02029482** · PHASE1 · COMPLETED · sponsor: **Actelion** · enrollment: 16 (actual)

## Conditions studied

- Safety and Tolerability

## Interventions

- **DRUG:** ACT-128800
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02029482
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2014-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02029482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02029482, "Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-128800 in Healthy Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02029482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*